maxcyte

MaxCyte, Inc.

MaxCyte is a cell-engineering company that provides technologies to support the development of cell-based therapeutics, from discovery to commercialization. They focus on enabling non-viral cell engineering using their Flow Electroporation® technology, which allows for the efficient and scalable modification of cells.

Content by MaxCyte, Inc.

Rethinking cell-based screening for faster therapeutic discovery
Available on Demand
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular rendering of antibody proteins with blue and gold surface structures floating against a soft blue background
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Gloved hand holding a microcentrifuge tube while a pipette dispenses liquid
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Illustration of a cell undergoing division, showing two connected daughter cells with visible nuclei, rendered in blue tones
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue